ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
THE MATRIX METALLOPROTEINASES AND THEIR NATURAL INHIBITORS - PROSPECTS FOR TREATING DEGENERATIVE TISSUE-DISEASES
Author(s): DOCHERTY AJP, OCONNELL J, CRABBE T, ANGAL S, MURPHY G
Source: TRENDS IN BIOTECHNOLOGY    Volume: 10    Issue: 6    Pages: 200-207    Published: JUN 1992  
Times Cited: 186     References: 77     
Abstract: Uncontrolled matrix metalloproteinase activity is thought to be a cause of the tissue damage observed in many disease processes. None of the drugs currently in use can prevent tissue destruction, and strategies for the development of synthetic inhibitors have been hampered by a poor understanding of the biochemistry of matrix metalloproteinases. Recent cDNA cloning efforts and characterization of recombinant human matrix metalloproteinases have permitted structure-function analysis of the enzymes and their inhibitors. Progress in this area should help indicate a route to rational strategies for designing lead therapeutic compounds.
Document Type: Review
Language: English
Reprint Address: DOCHERTY, AJP (reprint author), CELLTECH LTD, 216 BATH RD, SLOUGH SL1 4EN, ENGLAND
Addresses:
1. STRANGEWAYS RES LAB, CAMBRIDGE CB1 4RN, ENGLAND
Publisher: ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
Subject Category: Biotechnology & Applied Microbiology
IDS Number: JF752
ISSN: 0167-7799
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo